Riverside Haematology Group Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
1998
NCT00003603
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1998

Timeline

NOW
  • Now